Pre-clinical assessment of poly-arginine peptide R18D as a therapeutic to reduce central nervous system injury following neurotrauma

    StatusFinished
    Effective start/end date1/07/1730/06/18

    Funding

    • Neurotrauma Research Program (NRP)